Skip to main content
. 2023 Oct 16;4(2):100413. doi: 10.1016/j.xops.2023.100413

Table 2.

Characteristics of 8q Status of All SF3B1MUT Grouped Based on DFS in the Rotterdam Ocular Melanoma Study Group Cohort

SF3B1MUT Tumors DFS < 60 mos (n = 25) DFS ≥ 60 mos (n = 34)
2 copies of 8q, n (%) 4 (16) 7 (21)
3 copies of 8q, n (%) 16 (64) 21 (61)
≥ 4 copies of 8q, n (%) 5 (20) 6 (18)
8q gain, n (%) 21 (84) 27 (79)

DFS = disease-free survival; SF3B1MUT = splicing factor 3b subunit 1-mutated.